The Future of Obesity Treatment: How New Drugs Are Tackling a Global Crisis
The rise of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has transformed obesity management from a struggle of willpower to a targeted biological intervention. These injectable therapies, ... Read More